124 related articles for article (PubMed ID: 25131093)
1. Xenograft of microencapsulated Sertoli cells for the cell therapy of type 2 diabetes mellitus in spontaneously diabetic nonhuman primates: preliminary data.
Luca G; Cameron DF; Arato I; Mancuso F; Linden EH; Calvitti M; Falabella G; Szekeres K; Bodo M; Ricci G; Hansen BC; Calafiore R
Transplant Proc; 2014; 46(6):1999-2001. PubMed ID: 25131093
[TBL] [Abstract][Full Text] [Related]
2. Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus.
Luca G; Arato I; Mancuso F; Calvitti M; Falabella G; Murdolo G; Basta G; Cameron DF; Hansen BC; Fallarino F; Baroni T; Aglietti MC; Tortoioli C; Bodo M; Calafiore R
Xenotransplantation; 2016 Nov; 23(6):429-439. PubMed ID: 27678013
[TBL] [Abstract][Full Text] [Related]
3. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
4. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
5. Effect of chromium-enriched yeast on fasting plasma glucose, glycated haemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin.
Racek J; Sindberg CD; Moesgaard S; Mainz J; Fabry J; Müller L; Rácová K
Biol Trace Elem Res; 2013 Oct; 155(1):1-4. PubMed ID: 23921483
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the clinical manifestations of type 2 diabetes mellitus between rhesus monkey (Macaca mulatta lasiotis) and human being.
Gong L; Zeng W; Yang Z; Chen Z; Cheng A; Shen Y; Zeng L; Luo Q; Yang Y
Pancreas; 2013 Apr; 42(3):537-42. PubMed ID: 23303204
[TBL] [Abstract][Full Text] [Related]
7. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
8. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus.
Kong D; Zhuang X; Wang D; Qu H; Jiang Y; Li X; Wu W; Xiao J; Liu X; Liu J; Li A; Wang J; Dou A; Wang Y; Sun J; Lv H; Zhang G; Zhang X; Chen S; Ni Y; Zheng C
Clin Lab; 2014; 60(12):1969-76. PubMed ID: 25651730
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β-cell function in nonhuman primate model of diabetes.
Wang YJ; Wang X; An A; Zang M; Xu L; Gong K; Song W; Li Q; Lu X; Xiao YF; Yu G; Ma ZA
Fundam Clin Pharmacol; 2022 Aug; 36(4):699-711. PubMed ID: 35064580
[TBL] [Abstract][Full Text] [Related]
11. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
12. Xenograft of microencapsulated sertoli cells reverses T1DM in NOD mice by inducing neogenesis of beta-cells.
Luca G; Fallarino F; Calvitti M; Mancuso F; Nastruzzi C; Arato I; Falabella G; Grohmann U; Becchetti E; Puccetti P; Calafiore R
Transplantation; 2010 Dec; 90(12):1352-7. PubMed ID: 21197711
[TBL] [Abstract][Full Text] [Related]
13. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
Zang H; Jiang F; Cheng X; Xu H; Hu X
Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
[TBL] [Abstract][Full Text] [Related]
14. Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion.
Adami GF; Camerini G; Papadia F; Catalano MF; Carlini F; Cordera R; Scopinaro N
Obes Surg; 2019 Jan; 29(1):239-245. PubMed ID: 30232725
[TBL] [Abstract][Full Text] [Related]
15. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
[TBL] [Abstract][Full Text] [Related]
16. Screening for type 2 diabetes in obese youth.
Shah S; Kublaoui BM; Oden JD; White PC
Pediatrics; 2009 Aug; 124(2):573-9. PubMed ID: 19620188
[TBL] [Abstract][Full Text] [Related]
17. U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study.
Diabetes; 1985 Aug; 34(8):793-8. PubMed ID: 2862087
[TBL] [Abstract][Full Text] [Related]
18. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between insulin resistance and puberty in children with increased cardiometabolic risk].
Tobisch B; Blatniczky L; Barkai L
Orv Hetil; 2011 Jul; 152(27):1068-74. PubMed ID: 21676673
[TBL] [Abstract][Full Text] [Related]
20. Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.
Santilli F; Simeone PG; Guagnano MT; Leo M; Maccarone MT; Di Castelnuovo A; Sborgia C; Bonadonna RC; Angelucci E; Federico V; Cianfarani S; Manzoli L; Davì G; Tartaro A; Consoli A
Diabetes Care; 2017 Nov; 40(11):1556-1564. PubMed ID: 28912305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
